| Drugs by Condition |  |
Osteoarthritis Medications
Definition of Osteoarthritis:
Osteoarthritis is a chronic disease causing deterioration of the joint cartilage (the softer parts of bones, which cushion their connections to each other) and the formation of new bone (bone spurs) at the margins of the joints.
Drugs associated with Osteoarthritis
The following drugs and medications are in some way related to, or used in the treatment of Osteoarthritis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Osteoarthritis Medications in the Pipeline
- April 27, 2007 - Merck Receives Non Approvable Letter from FDA for Arcoxia (etoricoxib)
- April 13, 2007 - Public Citizen: FDA Should Not Approve "Offspring of Vioxx" Painkiller
- April 12, 2007 - FDA Advisory Committee Recommends Against Approval for Merck's NDA for Arcoxia (etoricoxib)
- April 11, 2007 - Statement by Merck & Co., Inc. Regarding FDA Arthritis Drugs Advisory Committee Meeting on Arcoxia (etoricoxib)
- April 9, 2007 - Arthritis Foundation Chief Public Health Officer Testifies at FDA Hearing on Arcoxia
- November 10, 2006 - Merck Responds to FDA-Issued Approvable Letters for Arcoxia (etoricoxib)
- June 17, 2005 - Merck Provides Status Update on Ongoing Arcoxia Trials
- October 29, 2004 - Merck Receives ’Approvable’ Letter for Arcoxia
- September 1, 2009 - Pozen Announces FDA Acceptance of NDA For Vimovo
- June 30, 2009 - Pozen Submits New Drug Application For Vimovo (PN 400)
- May 13, 2009 - Pozen Receives Decision from AstraZeneca to File PN 400 NDA
- November 18, 2009 - NicOx announces FDA accepts naproxcinod NDA for filing
- September 25, 2009 - NicOx submits New Drug Application (NDA) for naproxcinod to the US FDA
Latest Osteoarthritis Blog Post
CombinatoRx Presents Full Data on Synavive Phase 2 Knee OA Trial at EULAR 2009
-- Rapid and Sustained Efficacy Demonstrated with Synavive™ (CRx-102) --
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 12, 2009 - CombinatoRx, Incorporated (NASDAQ: CRXX) today announced the presentation of full data on Synavive (CRx-102) Phase 2 knee osteoarthritis...
View all Osteoarthritis blog posts.
Osteoarthritis Support Group Questions
Go to the Osteoarthritis support group or view all Osteoarthritis questions.
Ask a Question about Osteoarthritis:
Learn more about Osteoarthritis
Medical encyclopedia results for:
